Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 134 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: In vitro Diagnostic Clear all

Conditions: Strep Throat
Interventions: In Vitro Diagnostic Device aid in diagnosing; Device
Lead sponsor: Quidel Corporation; Industry
Eligibility: 3 Years and older
Enrollment: 1,282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 7
States / cities: Phoenix, Arizona • Carlsbad, California • San Diego, California + 4 more

Conditions: Infertility
Interventions: Not listed
Lead sponsor: Progyny, Inc.; Industry
Eligibility: Up to 43 Years · Female only
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 2
States / cities: Morristown, New Jersey • New York, New York

Conditions: Infertility, Endometriosis
Interventions: Elagolix 200 MG, Leuprolide Acetate 3.75 MG/ML, Lab work; Drug · Diagnostic Test
Lead sponsor: Colorado Center for Reproductive Medicine; Other
Eligibility: 21 Years to 42 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Lone Tree, Colorado

Conditions: Sinusitis Bacterial
Interventions: rapid in vitro diagnostic test, bacterial culture, PCR assay; Diagnostic Test
Lead sponsor: ENTvantage Dx; Industry
Eligibility: 18 Years and older
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 7
States / cities: Sacramento, California • DeLand, Florida • Port Saint Lucie, Florida + 4 more

Conditions: Cancer, Effects of Chemotherapy, Unspecified Complication of Bone Marrow Transplant, Auto Immune Disease
Interventions: Retrieval and Cryopreservation; Procedure
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 3 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 2
States / cities: Milwaukee, Wisconsin

Conditions: Infertility
Interventions: Single Embryo Transfer, Double embryo transfer; Other
Lead sponsor: Reproductive Medicine Associates of New Jersey; Other
Eligibility: 18 Years to 43 Years
Enrollment: 175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 2
States / cities: Morristown, New Jersey • Allentown, Pennsylvania

Conditions: Dengue
Interventions: Procleix Dengue Virus Assay; Device
Lead sponsor: Gen-Probe, Incorporated; Industry
Eligibility: Not listed
Enrollment: 150,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Gestational Diabetes
Interventions: Mellitus GCD59 Test; Diagnostic Test
Lead sponsor: Mellitus, LLC; Industry
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 19
States / cities: Birmingham, Alabama • Orange, California • Aurora, Colorado + 16 more

Conditions: Bloodstream Infection
Interventions: Accelerate PhenoTest™ BC kit, Standard of Care; Diagnostic Test
Lead sponsor: Accelerate Diagnostics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 774 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Acute Leukemia
Interventions: IUO Acute Leukemia Panel; Diagnostic Test
Lead sponsor: Becton, Dickinson and Company; Industry
Eligibility: 3 Years and older
Enrollment: 332 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 4
States / cities: Los Angeles, California • New York, New York • Chapel Hill, North Carolina + 1 more

Conditions: Dengue
Interventions: Procleix Dengue Virus Assay; Device
Lead sponsor: Gen-Probe, Incorporated; Industry
Eligibility: Not listed
Enrollment: 35,035 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Tempe, Arizona • Charlotte, North Carolina

Conditions: Covid19, Androgen Receptor Gene Overexpression
Interventions: COVID-19 Androgen Sensitivity Test (CoVAST); Genetic
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 90 Years · Male only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Irvine, California

Conditions: T-Cell Lymphoproliferative Disorder
Interventions: IdentiClone Dx TRG Assay; Diagnostic Test
Lead sponsor: Invivoscribe, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Solid Tumor, Adult, Colorectal Cancer, Non-Small Cell Lung, NSCLC (Non-small Cell Lung Cancer), Cancer, Colon Cancer, Rectal Cancer, Lung Cancer, CRC, Head and Neck Squamous Cell Cancer, HNSCC, Renal Cell Carcinoma, RCC, Kidney Cancer, Triple Negative Breast Cancer, TNBC, Colorectal Adenocarcinoma
Interventions: A2B395, xT CDx with HLA-LOH assay; Biological · Diagnostic Test
Lead sponsor: A2 Biotherapeutics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 10
States / cities: Gilbert, Arizona • La Jolla, California • Los Angeles, California + 7 more

Conditions: Staphylococcus Aureus
Interventions: Not listed
Lead sponsor: Solventum US LLC; Industry
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 8
States / cities: Phoenix, Arizona • Los Angeles, California • Decatur, Georgia + 5 more

Conditions: Bile Duct Stricture, Choledocholithiasis
Interventions: Blood draw for culture; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Stanford, California

Conditions: Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinomas
Interventions: Montanide (Registered Trademark) ISA-51 VG Adjuvant, H1299 Cell Lysates, N-803, Ventana PD-L1 (SP263 or SP142) assay; Biological · Drug · Device
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2035
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Kidney Transplantation
Interventions: NA-Observational only; Other
Lead sponsor: Biohope Scientific Solutions for Human Health, S.L.; Industry
Eligibility: 25 Years to 69 Years
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Interventions: Cyclophosphamide, Cytarabine, Dasatinib, Dexamethasone, Doxorubicin Hydrochloride, Idarubicin, Idelalisib, In Vitro Kinase Inhibitor Assay, Leucovorin Calcium, Methotrexate, Methylprednisolone Sodium Succinate, Ponatinib Hydrochloride, Rituximab, Ruxolitinib Phosphate, Sorafenib Tosylate, Sunitinib Malate, Vincristine Sulfate; Drug · Device · Biological
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 64 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Colorectal Cancer, Advanced Adenocarcinoma
Interventions: Signal-C™; Device
Lead sponsor: Universal Diagnostics; Industry
Eligibility: 45 Years to 84 Years
Enrollment: 12,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Raonoke, Virginia

Conditions: Chronic Kidney Diseases, Diabetic Kidney Disease
Interventions: KidneyIntelX; Diagnostic Test
Lead sponsor: Renalytix AI, Inc.; Industry
Eligibility: 23 Years and older
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Alopecia, Female Pattern Hair Loss
Interventions: 5% minoxidil topical foam; Drug
Lead sponsor: Applied Biology, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Tucson, Arizona • Nashville, Tennessee

Conditions: Transplant Sensitization, Panel Reactive Antibody, Sensitization to HLA Antigens
Interventions: Blood Draw; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Thrombocytopenia
Interventions: T-TAS 01 HD Assay; Diagnostic Test
Lead sponsor: Hikari Dx, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 6
States / cities: San Francisco, California • Denver, Colorado • Baltimore, Maryland + 3 more

Search by objective public record fields.

Strep A Fluorescent Immunoassay and Analyzer Field Study

Correlating Time-Lapse Parameters Detected by the Eeva™ System With Comprehensive Chromosome Screening Results

Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis

Point-of-Care Immunoassay for Detection of Bacterial Sinusitis

Ovarian Tissue Cryopreservation in Females Undergoing Procedures That Will Potentially Lead To Loss of Ovarian Function

Single Embryo Transfer of a Euploid Embryo Versus Double Embryo Transfer

Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS

Protocol to Validate the Performance of the Mellitus Glycated CD59 ELISA for Gestational Diabetes Screening

Genotypic Versus Phenotypic Susceptibility Testing of Positive Blood Cultures

Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cytometer

Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross

COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus

Prospective Study to Investigate the Frequency of Possible Bacterial Entry Into the Bloodstream (Bacteremia) and Infectious Complications Associated With the Use of the Spyglass Cholangioscopy System During ERCP (Endoscopic Retrograde Cholangiopancreatography).

Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer

Evaluation of Immunobiogram® as a Tool in Adjustment of Immunosuppressant Therapy for Renal Transplant

Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation

Real World Evidence Clinical Utility Study of KidneyIntelX

Minoxidil Response Testing in Females With Female Pattern Hair Loss

An In-vitro Standardization of B Cell Elispot Assays

Clinical Performance Evaluation of T-TAS®01 HD Chip